Do you want to read an article? Please log in or register.
Serum Reactive Oxygen Metabolite Levels Predict Severe Exacerbations of Asthma
Asthma
Related content
COMMENTED
Asthma
Effect of Vitamin D3 Supplementation on Severe Asthma Exacerbations in Children With Asthma and Low Vitamin D Levels: The VDKA Randomized Clinical Trial
★ 3
Recommended and commented by
Dr Martin Frey, Faculty Member
JAMA.
Forno E, Bacharier LB, Phipatanakul W, Guilbert TW, Cabana MD, Ross K, Covar R, Gern JE, Rosser FJ, Blatter J, Durrani S, Han YY, Wisniewski SR, Celedón JC
doi: 10.1001/jama.2020.12384.
Asthma
Baseline serum CXCL10 and IL-12 levels may predict severe asthmatics' responsiveness to omalizumab
Respir Med.
Suzukawa M, Matsumoto H, Ohshima N, Tashimo H, Asari I, Tajiri T, Niimi A, Nagase H, Matsui H, Kobayashi N, Shoji S, Ohta K
doi: 10.1016/j.rmed.
Asthma
Ability of Serum IgE Concentration to Predict Exacerbation Risk and Benralizumab Efficacy for Patients with Severe Eosinophilic Asthma
Adv Ther.
Jackson DJ, Humbert M, Hirsch I, Newbold P, Garcia Gil E
doi: 10.1007/s12325-019-01191-2.
RECOMMENDED
Asthma
Disconnect of type 2 biomarkers in severe asthma; dominated by FeNO as a predictor of exacerbations and periostin as predictor of reduced lung function
Respir Med.
Mansur AH, Srivastava S, Sahal A
doi: 10.1016/j.rmed.2018.08.005.
RECOMMENDED
Asthma
"T2-high" in severe asthma related to blood eosinophil, exhaled nitric oxide and serum periostin
Eur Respir J.
Pavlidis S, Takahashi K, Ng Kee Kwong F, Xie J, Hoda U, Sun K, Elyasigomari V, Agapow P, Loza M, Baribaud F, Chanez P, Fowler SJ, Shaw DE, Fleming LJ, Howarth PH, Sousa AR, Corfield J, Auffray C, De Meulder B, Knowles R, Sterk PJ, Guo Y, Adcock IM, Djukanovic R, Fan Chung K, on behalf of the U-BIOPRED Study Group
doi: 10.1183/13993003.
COPD
Serum levels of hyaluronic acid are associated with COPD severity and predict survival
Eur Respir J.
Papakonstantinou E, Bonovolias I, Roth M, Tamm M, Schumann D, Baty F, Louis R, Milenkovic B, Boersma W, Stieltjes B, Kostikas K, Blasi F, Aerts JG, Rohde GGU, Lacoma A, Torres A, Welte T, Stolz D
doi: 10.1183/13993003.
RECOMMENDED
Asthma
Baseline FeNO as a prognostic biomarker for subsequent severe asthma exacerbations in patients with uncontrolled, moderate-to-severe asthma receiving placebo in the LIBERTY ASTHMA QUEST study: a post-hoc analysis
★ 3
Recommended by
Dr Martin Frey, Faculty Member
★ 2
Recommended by
Dr Marcus Hesse, Faculty Member
Lancet Respir Med
Busse WW, Wenzel SE, Casale TB, FitzGerald JM, Rice MS, Daizadeh N, Deniz Y, Patel N, Harel S, Rowe PJ, Graham NMH, O'Riordan T, Pavord ID
doi: 10.1016/S2213-2600(21)00124-7
RECOMMENDED
Asthma
Evidence for Exacerbation-Prone Asthma and Predictive Biomarkers of Exacerbation Frequency
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Am J Respir Crit Care Med.
Peters MC, Mauger D, Ross KR, Phillips B, Gaston B, Cardet JC, Israel E, Levy BD, Phipatanakul W, Jarjour NN, Castro M, Wenzel SE, Hastie A, Moore W, Bleecker E, Fahy JV, Denlinger LC, National Heart Lung and Blood Institute Severe Asthma Research Program.
doi: 10.1164/rccm.201909-1813OC.
Asthma
Benralizumab efficacy by atopy status and serum immunoglobulin E for patients with severe, uncontrolled asthma
Ann Allergy Asthma Immunol.
Chipps BE, Newbold P, Hirsch I, Trudo F, Goldman M
doi: 10.1016/j.anai.2018.01.030.